All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Equity

MS takes position on Sfr400m Clariant rights issue

Clariant, the Swiss chemicals firm, has appointed Morgan Stanley to underwrite a Sfr400m rights issue in support of the Sfr2.5bn acquisition of privately-held Süd-Chemie that it announced on Wednesday. The US house acted as adviser to Clariant on the deal but whether a syndicate has been, or will be, formed remains to be confirmed.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree